PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Locally Advanced Breast Cancer
Recurrent Breast Cancer
Metastatic Breast Cancer
ER+ Breast Cancer
HER2-positive Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Avelumab

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]